In Vivo Toxicology Market by Product (Instruments, Animal models, and Reagents & Kits), by Testing Type (Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), and by Toxicity Endpoints (Systemic Toxicity, Immunotoxicity, and DART)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the in vivo toxicology market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the in vivo toxicology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the in vivo toxicology market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the in vivo toxicology market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the in vivo toxicology market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the in vivo toxicology market on the global and regional basis. 

The study provides a decisive view of the in vivo toxicology market by segmenting the market based on product, testing type, toxicity endpoints, and regions. The segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The product segment is segmented into instruments, animal models, and reagents & kits. Animal models segment held the maximum share of the product segment owing to rise in the development of genetically modified animals. Based on the testing type, in vivo toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoints, in vivo toxicology market is segmented into systemic toxicity, immunotoxicity, and DART.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further division into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for in vivo toxicology based on the individual segment in all the regions and countries.

The report also includes detailed profiles of end players such as Danaher, Charles River, Thermo Fisher, The Jackson Laboratory, and Covance, among others.

This report segments the global in vivo toxicology market as follows:

Global In Vivo Toxicology Market: By Product

	Instruments
	Animal models
	Reagents & Kits

Global In Vivo Toxicology Market: By Testing Type

	Chronic Toxicity Testing
	Sub-chronic Toxicity Testing
	Sub-acute Toxicity Testing
	Acute Toxicity Testing

Global In Vivo Toxicology Market: By Toxicity Endpoints

	Systemic Toxicity
	Immunotoxicity
	DART

Global In Vivo Toxicology Market: By Region

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	The Middle East and Africa